BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//jEvents 2.0 for Joomla//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:5e7cc2ace98fcbcadfda696cb4fa56bf
CATEGORIES:medicine
CREATED:20251023T093955
SUMMARY:Kalendarz szkoleń, konferencji, kursów - Multiple Myeloma Academy. Part 3. New Therapies and Supportive Care
LOCATION:ONLINE
URL;VALUE=URI:https://www.konferencjemedyczne.info/en/events/648/multiple-myeloma-academy
 -part-3-new-therapies-and-supportive-care.html?tmpl=component
DESCRIPTION:We invite you to participate in the webinar entitled: "Multiple Myeloma Aca
 demy. Part 3. New Therapies and Supportive Care," which will take place on 
 November 13, 2025, at 6:00 PM.\nDuring the meeting, invited guests will dis
 cuss the role of immunotoxins in multiple myeloma. Experts will also presen
 t the most important challenges related to the management of patients treat
 ed with belantamab mafodotin and the prevention and treatment of bone disea
 se in patients with multiple myeloma.\nThe event will conclude with a panel
  discussion, which will allow for the exchange of experiences and the prese
 ntation of diverse perspectives on new therapies and supportive care.\nDeta
 iled information and free registration can be found on the event website:\n
 https://hematoonkologia.pl/webinary/180-akademia-szpiczaka-plazmocytowego-c
 zesc-3-nowe-terapie-i-leczenie-wspomagajace\nWe invite you to participate!\
 n This event was imported from: https://www.konferencjemedyczne.info/en/eve
 nts/648/multiple-myeloma-academy-part-3-new-therapies-and-supportive-care.h
 tml?tmpl=component (https://www.konferencjemedyczne.info/en/events/648/mult
 iple-myeloma-academy-part-3-new-therapies-and-supportive-care.html?tmpl=com
 ponent)
X-ALT-DESC;FMTTYPE=text/html:<p>We invite you to participate in the webinar entitled: "Multiple Myeloma 
 Academy. Part 3. New Therapies and Supportive Care," which will take place 
 on November 13, 2025, at 6:00 PM.</p><p>During the meeting, invited guests 
 will discuss the role of immunotoxins in multiple myeloma. Experts will als
 o present the most important challenges related to the management of patien
 ts treated with belantamab mafodotin and the prevention and treatment of bo
 ne disease in patients with multiple myeloma.</p><p>The event will conclude
  with a panel discussion, which will allow for the exchange of experiences 
 and the presentation of diverse perspectives on new therapies and supportiv
 e care.</p><p>Detailed information and free registration can be found on th
 e event website:</p><p>https://hematoonkologia.pl/webinary/180-akademia-szp
 iczaka-plazmocytowego-czesc-3-nowe-terapie-i-leczenie-wspomagajace</p><p>We
  invite you to participate!</p> <a href="https://www.konferencjemedyczne.in
 fo/en/events/648/multiple-myeloma-academy-part-3-new-therapies-and-supporti
 ve-care.html?tmpl=component">This event was imported from: https://www.konf
 erencjemedyczne.info/en/events/648/multiple-myeloma-academy-part-3-new-ther
 apies-and-supportive-care.html?tmpl=component</a>DTSTAMP:20260430T222833
DTSTART;VALUE=DATE:20251113
DTEND;VALUE=DATE:20251114
SEQUENCE:0
TRANSP:OPAQUE
END:VEVENT
END:VCALENDAR